Latest filing published 26 Oct 2022 for Prime Medicine, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Thomas Cahill: trading record in brief
All filings by Thomas Cahill on record concern Prime Medicine, Inc. In total, 2 filings cover trades dated 24 October 2022.
No open-market sale appears; the market trades are 1 purchase worth €6.9M. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 26 October 2022 with a transaction in Prime Medicine, Inc. The last purchase on record was published on 26 October 2022, which is 1,476 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Thomas Cahill
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,905,679 sharesCommon StockSEC:0001628280-22-027122:0
- 400,000 shares@ US$17.00100.0% of flowCommon StockSEC:0001628280-22-027122:1Canonical exit: 22 Jan 2023 (T+90)
2 of 1 declaration
